Metronomic chemotherapy for indolent T‐cell lymphoproliferative disorder of the gastrointestinal tract

The present study proposes metronomic chemotherapy (CPT), including prednisolone, cyclophosphamide, and thalidomide, as a treatment for patients with severe symptomatic indolent T‐cell lymphoproliferative disorder of the gastrointestinal tract. The encouraging efficacy and excellent safety profile o...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Hailing, Cao, Lei, Zhao, Xiaoli, Miao, Yi, Wu, Wei, Shi, Xiao, Zhang, Xiaoyan, Yin, Hua, Zhu, Huayuan, Xu, Wei, Li, Jianyong, Fan, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
LETTER TO THE EDITOR
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475756/
https://www.ncbi.nlm.nih.gov/pubmed/37340510
http://dx.doi.org/10.1111/cas.15880

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475756/
https://www.ncbi.nlm.nih.gov/pubmed/37340510
http://dx.doi.org/10.1111/cas.15880

Ejemplares similares